This week’s roundup includes a series of articles on depression in menopausal women. Reducing depression during the menopausal transition with health coaching: Results from the healthy menopausal transition randomised controlled trial. Almeida OP, Marsh K, [...]
Multiple studies have demonstrated the effectiveness of antidepressant medications for the treatment of postpartum depression (PPD). Most of the these studies focused on the impact of these medications on depressive symptoms; however, it is [...]
Heading the list are two important reviews: one on postpartum psychosis from the American Journal of Psychiatry and another on the topic of perinatal suicide. On the list, you will also find several interesting [...]
The Edinburgh Postnatal Depression Scale (EPDS) is the screening instrument most commonly used to identify women with postpartum mood disorders. This is a 10-item questionnaire which has been validated in many different populations and is [...]
The U.S. Food and Drug Administration (FDA) has proposed major revisions to prescription drug labeling in order to provide more accurate and helpful information on the effects of medications used during pregnancy and breastfeeding. The [...]
Lately we are seeing more articles about postpartum anxiety. Although we typically emphasize postpartum depression, many women experience clinically significant symptoms of anxiety during pregnancy and the postpartum period. This week we have one article [...]
Peri- and postmenopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes; however, many menopausal women may have a primary sleep disorder, such as sleep [...]
In this week’s roundup, there are several interesting reviews. The first is from van der Zee-van den Berg AI (and colleagues with equally long names) on screening for postpartum depression at well-baby visits. From [...]
The use of the newer “atypical” or second-generation antipsychotic agents continues to increase. These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders. Although [...]
This week brings a large scale study on the reproductive safety of the newer atypical antipsychotic medications from Huybrechts and colleagues. To date, this is the largest sample of antipsychotic-exposed infants assessed, and the results [...]
